This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Foundation for Care Management (FCM) and the IACFS/ME. FCM is accredited by the ACCME to provide continuing medical education for physicians.
FCM designates this educational activity for a maximum of 23 AMA PRA Category 1 credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Foundation for Care Management is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval period: July 1, 2006—June 30, 2009. Provider # FCM-0303.
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program #347-999-09-004-L01-P.
Outcome Objectives:
Upon completion of these learning activities on CFS and Fibromyalgia, the healthcare provider should be able to:
- Discuss the prevalence and incidence and epidemiology of CFS and fibromyalgia.
- Describe chronic fatigue and fibromyalgia as it exists in different parts of the globe; how different cultural spheres handle these conditions and how research priorities differ in different settings
- Identify possible sources of public funding in the US for scientific and medical research in CFS, FM and related illnesses. Attendees from outside the U.S. will have knowledge of which grants are applicable for researchers from abroad.
- Examine through case studies, discussion, and reflection best practices in caring for patients with CFS and Fibromyalgia.
- Describe the chronic viral infections and reactivation of virus in chronic illness, methodological issues and the impact on conditions as CFS and fibromyalgia
- Identify the influence of genes on the pathophysiology in CFS and fibromyalgia, how gene arrays help in integrating multidiscipline data and the potential role of proteomics as a clinical tool.
- Discuss the definition of CFS and fibromyalgia in children and recommended treatment schemes.
- Develop an understanding of official attitudes from the US government as well as other governments on supplying health care with equal opportunities for women and men.
- Describe the biological causes of fatigue including interactive processes between neuro/immune/endocrine systems in the human body and possible therapeutic interventions.
- Describe the origins of pain and the best practices in the treatment of pain in fibromyalgia and CFS
- Describe advances in the assessment and diagnosis of CFS and fibromyalgia
- Discuss the new developments in pharmacologic treatments for fibromyalgia
- Identify treatment strategies for sleep problems in people with fibromyalgia and CFS.
- Describe strategies for treating the presumed primary mechanisms in CFS
- Discuss the effects of dysfunction in the human brain and the impact on human health in CFS and fibromyalgia.
- Discuss the influence of genes on the pathophysiology in CFS and fibromyalgia, how gene arrays help in integrating multidiscipline data and the potential role of proteomics as a clinical tool.
- Apply best practice strategies to appropriately diagnose and treat patients with CFS and/or Fibromyalgia to improve patient outcomes.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Foundation for Care Management (FCM) and the IACFS/ME. FCM is accredited by the ACCME to provide continuing medical education for physicians.
FCM designates this educational activity for a maximum of 23 AMA PRA Category 1 credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Foundation for Care Management is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval period: July 1, 2006—June 30, 2009. Provider # FCM-0303.
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program #347-999-09-004-L01-P.
Outcome Objectives:
Upon completion of these learning activities on CFS and Fibromyalgia, the healthcare provider should be able to:
- Discuss the prevalence and incidence and epidemiology of CFS and fibromyalgia.
- Describe chronic fatigue and fibromyalgia as it exists in different parts of the globe; how different cultural spheres handle these conditions and how research priorities differ in different settings
- Identify possible sources of public funding in the US for scientific and medical research in CFS, FM and related illnesses. Attendees from outside the U.S. will have knowledge of which grants are applicable for researchers from abroad.
- Examine through case studies, discussion, and reflection best practices in caring for patients with CFS and Fibromyalgia.
- Describe the chronic viral infections and reactivation of virus in chronic illness, methodological issues and the impact on conditions as CFS and fibromyalgia
- Identify the influence of genes on the pathophysiology in CFS and fibromyalgia, how gene arrays help in integrating multidiscipline data and the potential role of proteomics as a clinical tool.
- Discuss the definition of CFS and fibromyalgia in children and recommended treatment schemes.
- Develop an understanding of official attitudes from the US government as well as other governments on supplying health care with equal opportunities for women and men.
- Describe the biological causes of fatigue including interactive processes between neuro/immune/endocrine systems in the human body and possible therapeutic interventions.
- Describe the origins of pain and the best practices in the treatment of pain in fibromyalgia and CFS
- Describe advances in the assessment and diagnosis of CFS and fibromyalgia
- Discuss the new developments in pharmacologic treatments for fibromyalgia
- Identify treatment strategies for sleep problems in people with fibromyalgia and CFS.
- Describe strategies for treating the presumed primary mechanisms in CFS
- Discuss the effects of dysfunction in the human brain and the impact on human health in CFS and fibromyalgia.
- Discuss the influence of genes on the pathophysiology in CFS and fibromyalgia, how gene arrays help in integrating multidiscipline data and the potential role of proteomics as a clinical tool.
- Apply best practice strategies to appropriately diagnose and treat patients with CFS and/or Fibromyalgia to improve patient outcomes.